| Literature DB >> 29674312 |
Joseph Featherall1, Brittany Lapin2,3, Alexander Chaitoff1, Sonia A Havele4, Nicolas Thompson2,3, Irene Katzan1,2.
Abstract
BACKGROUND: Consumer health information technology can improve patient engagement in their health care and assist in navigating the complexities of health care delivery. However, the consumer health information technology offerings of health systems are often driven by provider rather than patient perspectives and inadequately address patient needs, thus limiting their adoption by patients. Consideration given to patients as stakeholders in the development of such technologies may improve adoption, efficacy, and consumer health information technology resource allocation.Entities:
Keywords: consumer health informatics; medical informatics; patient-centered care; self efficacy; self-management; telemedicine
Mesh:
Year: 2018 PMID: 29674312 PMCID: PMC6004033 DOI: 10.2196/jmir.7766
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Clinical characteristics of the study cohort (N=3852).
| Demographics | Value | |
| Age (years), mean (SD) | 57.0 (14.8) | |
| Female, n (%) | 2351 (61.03) | |
| White | 3115 (92.90) | |
| African American | 196 (5.85) | |
| Other | 42 (1.25) | |
| Married | 2204 (65.77) | |
| Single | 748 (22.32) | |
| Divorced/widowed | 399 (11.91) | |
| Household income (in US $)a, N=3326, median (Q1-Q3)b | 54,578 (44,371-66,360) | |
| Any comorbid condition, N=2615, n (%) | 2087 (79.81) | |
| Number of comorbiditiesc, median (Q1-Q3) | 2 (1-3) | |
| PHQ-9d, N=3434 | 6 (2-11) | |
| EQ-5De, N=3483 | 0.78 (0.60-0.83) | |
| Health efficacy score, N=3791 | 15 (12-17) | |
| Smartphone ownership (N=3799) | 2640 (69.49) | |
| Tablet ownership (N=3809) | 2103 (55.21) | |
aMedian household income by zip code.
bQ1: first quartile, Q3: third quartile.
cComorbid conditions include diabetes, atrial fibrillation, cancer, coronary artery disease, chronic renal insufficiency, and hypertension.
dPHQ-9: Patient Health Questionnaire-9.
eEQ-5D: EuroQol 5 Dimensions.
Figure 1Response distribution to consumer health information technology interest survey questions. Response distributions (n) are shown for the level of interest to each question on the health information technology survey. Questions are grouped by category: education, communication, and self-management.
Multivariable predictors of consumer health information technology (CHIT) outcomes: education, communication, and self-management.
| Predictors | Education | Communication | Self-management | ||||
| ORa (95% CI) | OR (95% CI) | OR (95% CI) | |||||
| Age (per decade) | 0.98 (0.89-1.07) | .60 | 0.98 (0.89-1.08) | .67 | 0.89 (0.81-0.97) | .01 | |
| Female Gender | 0.97 (0.78-1.22) | .80 | 1.20 (0.96-1.50) | .12 | 0.99 (0.80-1.22) | .89 | |
| White | Reference | Reference | Reference | ||||
| African American | 1.46 (0.96-2.22) | .08 | 1.12 (0.70-1.77) | .64 | 1.48 (0.97-2.26) | .07 | |
| Other | 1.48 (0.55-3.94) | .44 | 2.16 (0.61-7.65) | .23 | 1.33 (0.51-3.50) | .56 | |
| Married | Reference | Reference | Reference | ||||
| Single | 1.12 (0.85-1.48) | .43 | 0.85 (0.64-1.41) | .28 | 1.02 (0.78-1.33) | .90 | |
| Divorced/widowed | 1.29 (0.95-1.76) | .11 | 0.80 (0.58-1.09) | .15 | 1.09 (0.81-1.46) | .58 | |
| Income (per US $10k) | 0.99 (0.93-1.06) | .81 | 1.06 (0.99-1.13) | .09 | 1.04 (0.98-1.10) | .26 | |
| PHQ-9b | 1.04 (1.01-1.06) | .003 | 1.04 (1.02-1.07) | <.001 | 1.05 (1.03-1.08) | <.001 | |
| EQ-5Dc Index (per 0.1) | 0.92 (0.86-0.98) | .01 | 0.98 (0.92-1.05) | .58 | 0.97 (0.91-1.03) | .32 | |
| Health self-efficacy score | 1.20 (1.16-1.25) | <.001 | 1.12 (1.08-1.16) | <.001 | 1.15 (1.11-1.19) | <.001 | |
| Smart phone ownership | 1.83 (1.43-2.34) | <.001 | 1.75 (1.39-2.22) | <.001 | 1.77 (1.41-2.21) | <.001 | |
| Any comorbidityd | 0.82 (0.62-1.07) | .14 | 1.10 (0.83-1.48) | .49 | 1.05 (0.81-1.37) | .72 | |
aOR: odds ratio.
bPHQ-9: Patient Health Questionnaire-9.
cEQ-5D: Euroqol 5 Dimensions.
dComorbid conditions include diabetes, atrial fibrillation, cancer, coronary artery disease, chronic renal insufficiency, and hypertension.